Abstract
BackgroundRespiratory virus infections are a major cause of morbidity in early life. During the SARS-CoV-2 pandemic, non-pharmaceutical interventions (NPIs) lead to worldwide changes in respiratory virus epidemiology. However, evidence regarding...
Published Version
Join us for a 30 min session where you can share your feedback and ask us any queries you have